“Life moves pretty fast. If you don’t stop and look around once in a while, you could miss it.”
Ferris Bueller’s Day Off
Ferris packed an afternoon at Wrigley, a joy ride in a classic, and a parade takeover into one day. Not everyone’s version of a perfect day, but he embodied a kind of vicarious living worth experiencing.
In Ferris we longed for that feeling of freedom and memory making, but we mostly know the opposite, the version of a day that runs through you rather than the other way around.
That’s autopilot, and it looks like five hundred commutes you don’t remember, two years of quarterly reviews that blur into one gray afternoon, and kids who were begging you to play a minute ago and now just ask for the credit card.
A day on repeat doesn’t ask much of you. A day like Ferris’s does. The brain works the way muscle does responding to what you ask of it. Coasting on the same five hundred commutes is not much of an ask.
Picture cognitive decline, and a scene comes to mind, a diagnosis, a bad scan, a hard conversation, all coming at once. That’s rarely how it happens, though. Brain change behaves like plaque in an artery building slowly for years before a symptom appears. Which is why “I’d know if something were different” is one of the least reliable things you can tell yourself.
THE BIG IDEA
Close to half of dementia risk comes down to what you ask of your mind, day to day, year to year.
We talk about dementia the way we talk about the rain, something that just happens or doesn’t. A parent’s diagnosis becomes the whole forecast, when it’s really one input among many.
The research, though, points to something more hopeful. The 2024 Lancet Commission on dementia prevention found that up to 45 percent of dementia cases could potentially be delayed or prevented by addressing 14 modifiable risk factors across a lifetime including by changing blood pressure, hearing, vision, movement, sleep, and how connected you stay to other people.
It doesn’t require extensive testing, and most of these markers are already captured in a medical intake form. The problem is follow-through, not information. While heart health establishes a baseline and an ongoing plan from day one, too often, brain health gets attention only after something has already gone wrong.
Three Ideas Brain Research Agrees On
01
Risk builds for decades before symptoms.
Brain changes typically begin ten to twenty years before the first noticeable symptom.
02
Almost half of it is within reach.
The Lancet Commission’s 2024 update puts up to 45 percent of dementia cases as potentially delayable or preventable.
03
Movement changes the trajectory.
The fastest-walking adults in their 80s showed roughly 50 percent lower risk of cognitive decline.
Three consistent findings across current dementia prevention research.
THE SCIENCE
What’s Actually Going On
Most people know their blood pressure, even a rough one. Ask about their brain, though, and you’ll get a shrug, a joke about forgetting where the keys are, or maybe a story about a parent. There’s no equivalent number, mostly because until recently there wasn’t much to measure or do about it. That’s changing. Here’s what’s new this year, and how to use it.
The list got longer. In 2024, the Lancet Commission expanded its modifiable dementia risk factor list from twelve to fourteen, adding untreated vision loss in later life and high LDL cholesterol at midlife. Combined with hearing loss, hypertension, smoking, physical inactivity, diabetes, excess alcohol, obesity, depression, social isolation, less education, air pollution, and traumatic brain injury, addressing all fourteen factors could lower dementia risk by up to 45 percent, up from the 40 percent estimate in the 2020 report. (Lancet Commission on dementia prevention, intervention, and care, 2024.)
Movement. A 2026 study in Neurology followed nearly 4,000 older adults and identified what researchers called “super movers,” the fastest-walking 9 percent for their age. That group had roughly 50 percent lower risk of cognitive decline and kept more hippocampal volume as they aged, even when some showed the amyloid plaques associated with Alzheimer’s without any symptoms. (Milman et al., Neurology, 2026.)
Detection is catching up. In August 2026, the FDA cleared Roche’s Elecsys pTau217 blood test, which measures a tau protein linked to amyloid buildup in the brain, the fourth blood-based Alzheimer’s biomarker test cleared to date. It can help evaluate Alzheimer’s-related pathology in appropriately selected patients with cognitive symptoms, not as a screening tool for healthy adults. It turns what used to require a specialist referral, a PET scan, or a spinal tap into a blood draw. (Alzheimer’s Association / Roche, 2026.)
A positive result usually isn’t the finish line, it’s a step toward an amyloid PET scan, a brain-imaging test that can directly detect amyloid plaque, which can confirm whether someone is a candidate for two newer FDA-approved treatments: Kisunla (donanemab) and Leqembi (lecanemab). Both are antibodies that remove amyloid from the brain and modestly slow decline in early Alzheimer’s disease. Neither cures the disease nor restores memory already lost, and both are reserved for mild cognitive impairment or mild dementia with confirmed amyloid pathology. For members without symptoms, the same conversation often becomes a concrete reason to make the prevention work more consistent.
Genetics still matter, and they’re not nothing. Understanding what’s measurable right now, and acting on it, matters more.
Guideline-Recommended
Blood Pressure
The Vascular Link
One of the strongest modifiable factors on the Lancet list. What protects arteries protects the brain they feed.
Hearing Screen
Skipped Most Often
Untreated hearing loss is one of the largest single modifiable contributors on the list, and one of the more overlooked fixes.
Vision Screen
Added In 2024
Untreated vision loss joined the Lancet risk list as a new factor in 2024. An outdated prescription is not a cosmetic issue.
hsCRP
Inflammation, Tracked
A marker of systemic inflammation linked to faster cognitive decline when left elevated over years.
Homocysteine
The Overlooked Number
Elevated levels are linked to brain volume loss over time and rarely appear on a standard panel.
Additional Signal, By Discussion
Blood biomarkers, genetic testing, and cognitive assessments answer different questions, and none of them should be read alone. If either test is on the table, we’ll walk through what a result could actually change, its limits, what follow-up looks like, and, for genetic testing, the family and insurance implications, before you decide. Healthy members can act on every established brain-health risk in this issue without either one.
pTau217 Test
Newly Cleared, For Symptoms
A blood draw that measures a tau protein tied to amyloid buildup. FDA-cleared in August 2026 to help evaluate Alzheimer’s-related pathology in appropriately selected patients with cognitive symptoms.
ApoE Genotype
One Piece, Not The Picture
A gene test for the APOE-e4 variant tied to higher Alzheimer’s risk, not a diagnosis. Testing calls for an informed discussion beforehand, and careful interpretation of results with an MD.
Three consistent findings across current dementia prevention research.
The Practice
What It Actually Takes
Like most of what we discuss, a solid step forward requires just a short list of habits, done consistently enough that they compound.
Walk like it counts: Not just steps but pace. A block of faster-than-comfortable walking, 20 to 30 minutes a few times a week, is close to the free intervention the gait research turned up. If Zone 2 is already a habit, add short bursts where you deliberately pick up the pace.
Fix the senses, don’t just monitor them: Book the hearing test you’ve been putting off, and update the eyewear prescription that’s a year or two stale. Both are on the Lancet risk list, and both are usually a same-month fix.
Put people on the calendar: Social isolation carries real weight on the Lancet list, alongside blood pressure and smoking. A standing dinner, a call instead of a text, anything that gets you in a room with people counts as much as a lab number.
Where It Break
Where Most Systems Break
The “I’d know” assumption. You’d assume you’d notice your own cognitive change first. In practice, the person closest to a slow decline is often the last to see it, and the people around them are the first. If someone who knows you well mentions a change twice, that’s worth a conversation.
The decade nobody checks. Midlife, roughly the 40s through the 50s, is when high LDL cholesterol and rising blood pressure do the most damage to future brain health, and it’s also the decade people are busiest and least likely to be tracking either number. Check them, speak with an MD about them, and do something about them.
The Bigger Picture
The Long View
Cognitive health fits the same pattern as everything else Sperity Health tracks. Know the data, catch problems early, and adjust what’s within reach. The difference here is what’s actually at stake in the meantime.
A missed cardiovascular risk factor can shorten a life. A missed cognitive one can change who is present for the years that are still there for you and for the people counting on you to be paying attention.
Life moves pretty fast. Ferris never tried to slow it down. He paid enough attention to remember all of it. That’s the ask here too, a brain that can keep up with your life and hold onto it for as long as possible.
Additional Reading
Stay Informed. Stay Healthier
Receive practical health insights and the latest Sperity news.